• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

国际上关于双相情感障碍管理的循证指南之间是否存在共识?

Is there consensus across international evidence-based guidelines for the management of bipolar disorder?

作者信息

Parker G B, Graham R K, Tavella G

机构信息

School of Psychiatry, University of New South Wales, Sydney, NSW, Australia.

Black Dog Institute, Sydney, NSW, Australia.

出版信息

Acta Psychiatr Scand. 2017 Jun;135(6):515-526. doi: 10.1111/acps.12717. Epub 2017 Mar 5.

DOI:10.1111/acps.12717
PMID:28260229
Abstract

OBJECTIVE

To examine the level of agreement across professionally auspiced evidence-based guidelines for managing the bipolar disorders.

METHODS

A literature search in PubMed, the National Guideline Clearinghouse, the Cochrane Database of Systematic Reviews and PsycInfo was undertaken using the search terms 'bipolar disorder' and 'guidelines', generating 11 evidence-based guidelines published by professional organisations over the 2002-2015 period. Each guideline was reviewed by two independent reviewers and key themes extracted via qualitative analyses.

RESULTS

There was agreement on issues such as the first-line treatment of mania where mood-stabilising and/or an antipsychotic medication together with tapering or ceasing antidepressant medications was most commonly recommended. Differences included the extent to which (i) the different bipolar disorders were defined or not, (ii) there were separate recommendations for bipolar I and bipolar II disorders vs. non-differentiating general bipolar management strategies, (iii) 'general' vs. severity-based recommendations were made, and (iv) narrow vs. broad sets of candidate medications were nominated, while there was variable consideration of treatments such as electroconvulsive therapy (ECT).

CONCLUSIONS

While there was some consistency across guidelines on key recommendations, there was also substantial inconsistencies, limiting the generation of any 'meta-consensus' model for managing the bipolar disorders.

摘要

目的

检验专业认可的双相情感障碍管理循证指南之间的一致程度。

方法

在PubMed、国家指南库、Cochrane系统评价数据库和PsycInfo中进行文献检索,检索词为“双相情感障碍”和“指南”,共检索到专业组织在2002年至2015年期间发布的11项循证指南。由两名独立评审员对每项指南进行评审,并通过定性分析提取关键主题。

结果

在一些问题上达成了共识,如躁狂发作的一线治疗,最常推荐使用心境稳定剂和/或抗精神病药物,并逐渐减少或停用抗抑郁药物。差异包括:(i)对不同双相情感障碍的定义程度;(ii)对双相I型和双相II型障碍有单独推荐,还是采用非区分性的一般双相管理策略;(iii)做出“一般”推荐还是基于严重程度的推荐;(iv)提名的候选药物范围窄还是宽,同时对电休克治疗(ECT)等治疗方法的考虑也各不相同。

结论

虽然指南在关键推荐方面存在一些一致性,但也存在大量不一致之处,限制了生成任何用于双相情感障碍管理的“元共识”模型。

相似文献

1
Is there consensus across international evidence-based guidelines for the management of bipolar disorder?国际上关于双相情感障碍管理的循证指南之间是否存在共识?
Acta Psychiatr Scand. 2017 Jun;135(6):515-526. doi: 10.1111/acps.12717. Epub 2017 Mar 5.
2
Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period?在围产期,国际循证指南对双相情感障碍的精神药物治疗是否存在共识?
J Affect Disord. 2018 Mar 1;228:216-221. doi: 10.1016/j.jad.2017.12.022. Epub 2017 Dec 12.
3
Systematic review of recent guidelines for pharmacological treatments of bipolar disorders in adults.成人双相情感障碍药物治疗近期指南的系统评价
Ann Clin Psychiatry. 2017 Nov;29(4):266-282.
4
Treatments for late-life bipolar disorder.老年双相情感障碍的治疗方法。
Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007.
5
[Methodological approach to inter "guideline" variability in the management of bipolar disorders].[双相情感障碍管理中“指南”间变异性的方法学探讨]
Encephale. 2012 Apr;38(2):126-32. doi: 10.1016/j.encep.2011.07.004. Epub 2011 Aug 31.
6
Balanced efficacy, safety, and tolerability recommendations for the clinical management of bipolar disorder.平衡疗效、安全性和耐受性推荐用于双相情感障碍的临床管理。
Bipolar Disord. 2012 May;14 Suppl 2:1-21. doi: 10.1111/j.1399-5618.2012.00989.x.
7
The use of lithium for the treatment of bipolar disorder: Recommendations from clinical practice guidelines.锂盐用于双相情感障碍治疗:临床实践指南推荐意见
J Affect Disord. 2017 Aug 1;217:266-280. doi: 10.1016/j.jad.2017.03.052. Epub 2017 Mar 27.
8
Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation.比较单相抑郁治疗指南:关注药物治疗和神经刺激。
Acta Psychiatr Scand. 2018 Jun;137(6):459-471. doi: 10.1111/acps.12878. Epub 2018 Mar 25.
9
[Prescribed drug use for bipolar disorder type I and II in clinical practice].[临床实践中用于I型和II型双相情感障碍的处方药使用情况]
Lakartidningen. 2017 Jan 10;114:D77T.
10
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders.澳大利亚和新西兰皇家精神科医学院心境障碍临床实践指南
Aust N Z J Psychiatry. 2015 Dec;49(12):1087-206. doi: 10.1177/0004867415617657.

引用本文的文献

1
Prescribing lithium for the management of persons suffering from bipolar disorders: expert consensus based on a Delphi study.开具锂盐用于双相情感障碍患者的治疗:基于德尔菲研究的专家共识
Int J Bipolar Disord. 2025 Jun 7;13(1):21. doi: 10.1186/s40345-025-00387-6.
2
Safety Profile of Lithium: A Disproportionality Analysis Using the FDA Adverse Event Reporting System.锂的安全性概况:使用美国食品药品监督管理局不良事件报告系统的不成比例性分析
Neuropsychobiology. 2025 May 30:1-9. doi: 10.1159/000546602.
3
Lifelong Pharmacoprophylaxis in Bipolar Disorder: Holy Grail or Hollow Promise?
双相情感障碍的终身药物预防:圣杯还是空洞的承诺?
Indian J Psychol Med. 2025 Jan 31:02537176251313523. doi: 10.1177/02537176251313523.
4
Aripiprazole/Sertraline Combination: Clinical and Cost-Effectiveness in Comparison With Quetiapine for the Treatment of Bipolar Depression (ASCEnD Trial)-Protocol for a Nested Qualitative Study.阿立哌唑/舍曲林联合治疗与喹硫平治疗双相抑郁的临床和成本效益比较(ASCEnD 试验)-嵌套定性研究方案。
Health Expect. 2024 Oct;27(5):e70018. doi: 10.1111/hex.70018.
5
The Right to Equal Health: Best Practice Priorities for Māori with Bipolar Disorder from Staff Focus Groups.平等健康权:员工焦点小组针对患有双相情感障碍的毛利人的最佳实践优先事项
Healthcare (Basel). 2024 Apr 6;12(7):793. doi: 10.3390/healthcare12070793.
6
Why is lithium [not] the drug of choice for bipolar disorder? a controversy between science and clinical practice.为什么锂盐不是双相情感障碍的首选药物?科学与临床实践之间的一场争论。 (注:原句中括号里的not根据语境判断不应有,否则语义不通顺,所以翻译时未保留)
Int J Bipolar Disord. 2024 Jan 16;12(1):3. doi: 10.1186/s40345-023-00322-7.
7
A naturalistic effectiveness study of maintenance therapies for the bipolar disorders.双相障碍维持治疗的自然疗效研究。
Acta Psychiatr Scand. 2024 Feb;149(2):98-109. doi: 10.1111/acps.13646. Epub 2023 Dec 10.
8
Korean Medication Algorithm Project for Bipolar Disorder 2022: Comparisons with Other Treatment Guidelines.2022年韩国双相情感障碍药物治疗算法项目:与其他治疗指南的比较
Clin Psychopharmacol Neurosci. 2023 Feb 28;21(1):32-48. doi: 10.9758/cpn.2023.21.1.32.
9
Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Meta-Analysis of Pharmacotherapy.女性心理健康治疗的母婴及儿童结局:药物治疗的荟萃分析
Psychiatr Res Clin Pract. 2021 May 4;3(3):123-140. doi: 10.1176/appi.prcp.20210001. eCollection 2021 Fall.
10
A randomized controlled trial of customized adherence enhancement (CAE-E): study protocol for a hybrid effectiveness-implementation project.一项定制的依从性增强(CAE-E)随机对照试验:一项混合有效性实施项目的研究方案。
Trials. 2022 Aug 4;23(1):634. doi: 10.1186/s13063-022-06517-0.